Heron Therapeutics, Inc.

HRTX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000818033

SEC filings (opens in a new tab)

No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Heron Therapeutics, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of HRTX: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	161	3	165	+7
Shares	114.9M	320.4K	124.8M	+10.2M (+8.9%)
Value	$175.8M	$490.2K	$274.5M	+$99.2M (+56.6%)

3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Heron Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to HRTX in Q1 2025
Institution	Shares	Value	% of portfolio
AIGH Capital Management LLC	2,778,200	$6.11M	3.17%
Citadel Advisors LLC	501,490	$1.10M	0.00%
TD Asset Management Inc	394,600	$868.1K	0.00%
EAM Investors, LLC	349,000	$767.8K	0.13%
Jefferies Financial Group Inc.	322,600	$709.7K	0.01%
Nuveen, LLC	314,275	$691.4K	0.00%
Palumbo Wealth Management LLC	124,103	$273.0K	0.09%
Creative Planning	98,452	$216.6K	0.00%
Brevan Howard Capital Management LP	77,541	$170.6K	0.00%
Horan Securities, Inc.	41,590	$91.5K	0.03%
ExodusPoint Capital Management, LP	38,699	$85.0K	0.00%
Wealth Alliance	32,000	$70.4K	0.01%
HRT Financial LP	29,231	$64.0K	0.00%
Bank of Montreal	26,101	$57.4K	0.00%
CIBC World Markets Inc.	25,900	$57.0K	0.00%
Lazard Asset Management LLC	13,815	$30.0K	0.00%
RFP Financial Group LLC	11,776	$25.9K	0.01%
Balyasny Asset Management LLC	11,492	$25.3K	0.00%
Prudential Financial Inc	11,015	$24.2K	0.00%
N.E.W. Advisory Services LLC	1,619	$3.56K	0.00%
Coldstream Capital Management Inc	1,224	$2.69K	0.00%
US Bancorp	726	$1.60K	0.00%
Optiver Holding B.V.	424	$933	0.00%
HighMark Wealth Management LLC	100	$220	0.00%
True Wealth Design, LLC	11	$25	0.00%

Sold out (18)

Institutions that held Heron Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of HRTX in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Zweig-DiMenna Associates LLC	128,592	$196.7K
Verition Fund Management LLC	102,843	$157.3K
Aristides Capital LLC	52,849	$80.9K
Arkadios Wealth Advisors	50,000	$76.5K
State of Wyoming	29,736	$45.5K
Engineers Gate Manager LP	27,607	$42.2K
Colony Group, LLC	20,000	$30.6K
Point72 (DIFC) Ltd	18,924	$29.0K
Wolverine Trading, LLC	12,330	$18.6K
Simplex Trading, LLC	7,498	$11.0K
Proequities, Inc.	1,280	$2.09K
SRS Capital Advisors, Inc.	1,035	$1.58K
R Squared Ltd	990	$1.51K
Jones Financial Companies LLLP	476	$728
Huntington National Bank	370	$566
Eagle Bay Advisors LLC	193	$295
GeoWealth Management, LLC	173	$265
IFP Advisors, Inc	35	$54

Not filed for Q1 2025 yet (3)

Institutions that held Heron Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HRTX in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	314,275	$480.8K
Global Retirement Partners, LLC	4,018	$6.15K
WR Wealth Planners, LLC	2,100	$3.21K